|
|
|
|
Vol. 58, Issue 1, 226-236, July 2000
s Carboxyl-Terminal Peptide Prevents
Gs Activation by the A2A Adenosine Receptor
Dipartimento di Psichiatria, Neurobiologia, Farmacologia e
Biotecnologie, Università di Pisa, Pisa, Italy (M.R.M., S.T.,
L.G., A.L.); Dipartimento di Scienze Farmaceutiche, Università di
Salerno, Salerno, Italy (P.R., A.D., S.A.); Dipartimento di Chimica
Farmaceutica e Tossicologica, Università di Napoli "Federico
II", Napoli, Italy (E.N., G.G.); Istituto di Mutagenesi e
Differenziamento, Peptide Synthesis Lab, Consiglio Nazionale delle
Ricerche, Pisa, Italy (C.G.); Menarini Ricerche, Firenze, Italy (A.T.);
and Northwestern University Institute for Neuroscience, Department of
Molecular Pharmacology and Biological Chemistry, Chicago, Illinois
(H.E.H.)
The molecular mechanisms of interaction between
Gs and the A2A adenosine receptor were
investigated using synthetic peptides corresponding to various segments
of the G
s carboxyl terminus. Synthetic peptides were
tested for their ability to modulate binding of a selective
radiolabeled agonist,
[3H]2-[4-(2-carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamidoadenosine ([3H]CGS21680), to A2A adenosine receptors in
rat striatal membranes. The G
s peptides stimulated
specific binding both in the presence and absence of 100 µM
guanosine-5'-O-(3-thiotriphosphate) (GTP
S). Three
peptides, G
s(378-394)C379A,
G
s(376-394)C379A, and
G
s(374-394)C379A, were the most
effective. In the presence of GTP
S, peptide G
s(374-394)C379A increased specific binding
in a dose-dependent fashion. However, the peptide did not stabilize the
high-affinity state of the A2A adenosine receptor for
[3H]CGS21680. Binding assays with a radiolabeled
selective antagonist, [3H]5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine ([3H]SCH58261), showed that the addition of the
G
s peptide modified the slope of the
5'-N-ethylcarboxamidoadenosine (NECA) competition curve,
suggesting modulation of receptor affinity states. In the presence of
GTP
S, the displacement curve was right-shifted, whereas the addition
of G
s(374-394)C379A caused a partial
left-shift. Both curves were fitted by one-site models. This same
G
s peptide was also able to disrupt
Gs-coupled signal transduction as indicated by inhibition
of the A2A receptor-stimulated adenylyl cyclase activity
without affecting either basal or forskolin-stimulated enzymatic
activity in the same membrane preparations. Shorter peptides from
G
s and G
i1/2 carboxyl termini were not
effective. NMR spectroscopy showed the strong propensity of peptide
G
s(374-394)C379A to assume a compact
carboxyl-terminal
-helical conformation in solution. Overall, our
results point out the conformation requirement of G
s
carboxyl-terminal peptides to modulate agonist binding to rat
A2A adenosine receptors and disrupt signal transduction.
This article has been cited by other articles:
![]() |
J.-S. Huang, L. Dong, T. Kozasa, and G. C. Le Breton Signaling through G{alpha}13 Switch Region I Is Essential for Protease-activated Receptor 1-mediated Human Platelet Shape Change, Aggregation, and Secretion J. Biol. Chem., April 6, 2007; 282(14): 10210 - 10222. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. D'Ursi, L. Giusti, S. Albrizio, F. Porchia, C. Esposito, G. Caliendo, C. Gargini, E. Novellino, A. Lucacchini, P. Rovero, et al. A Membrane-Permeable Peptide Containing the Last 21 Residues of the G{alpha}S Carboxyl Terminus Inhibits GS-Coupled Receptor Signaling in Intact Cells: Correlations between Peptide Structure and Biological Activity Mol. Pharmacol., March 1, 2006; 69(3): 727 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mollereau, H. Mazarguil, J.-M. Zajac, and M. Roumy Neuropeptide FF (NPFF) Analogs Functionally Antagonize Opioid Activities in NPFF2 Receptor-Transfected SH-SY5Y Neuroblastoma Cells Mol. Pharmacol., March 1, 2005; 67(3): 965 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Schwindinger, K. E. Giger, K. S. Betz, A. M. Stauffer, E. M. Sunderlin, L. J. Sim-Selley, D. E. Selley, S. K. Bronson, and J. D. Robishaw Mice with Deficiency of G Protein {gamma}3 Are Lean and Have Seizures Mol. Cell. Biol., September 1, 2004; 24(17): 7758 - 7768. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Feldman, A. M. Zamah, K. L. Pierce, W. E. Miller, F. Kelly, A. Rapacciuolo, H. A. Rockman, W. J. Koch, and L. M. Luttrell Selective Inhibition of Heterotrimeric Gs Signaling. TARGETING THE RECEPTOR-G PROTEIN INTERFACE USING A PEPTIDE MINIGENE ENCODING THE Galpha s CARBOXYL TERMINUS J. Biol. Chem., August 2, 2002; 277(32): 28631 - 28640. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF] |
||||